Burdinola acquires 49% of Burdinola Benelux SRL and takes control of 100% of the Belgian subsidiary The company goes further in its internationalization strategy and growth objectives with the acquisition of 100% of the subsidiary created in 2017

Since its creation, the subsidiary follows up the global strategy of Burdinola, focused on its position in safe laboratories and focused on attracting large projects.

There are positive growth forecasts for the subsidiary for the coming years. We already have an interesting portfolio of orders in first-class customers and sectors, such as UCB Pharma (the main Belgian pharmaceutical company) or Dow Chemical Company, among others.

“With our Belgian subsidiary we seek to position ourselves as a leader in a market / area in which we have good growth forecasts and strengthen in this way our leadership in European countries where we are located. In this sense, we believe that our specialization in safe laboratories brings differentiation and added value to our technical proposal“, declares Mikel Martínez, CEO of Burdinola.

Burdinola Benelux joins the network of Burdinola subsidiaries, located in France, Italy, United Kingdom and UAE (Dubai). It is completed with delegations in Mexico, Peru and Colombia, in addition to a wide commercial presence in Spain with 5 delegations.

Images BeNeLux_805_417

» back